How Dogs Can Be Used in Research and Science with Kayla Fratt Co-Founder of K9 Conservationists
Listen now
Description
We’re going to deviate from our typical life sciences for just a few moments just for fun to talk about dogs. We’ve heard about dogs using their olfactory system to detect biologic changes related to disease. Having a bit of a soft spot for dogs ourselves here at Qualio, when our friend Kayla Fratt reached out to be on the show, we thought it’d be fun to hear about her work in ecology and in the field doing conservation work. Kayla is the founder of K9 Conservationists and Journey Dog Training. She trains dogs to detect data for researchers, agencies, and NGOs. Along with the rest of the K9 Conservationists team, Kayla travels the world collecting data with her dogs and offering support to conservation detection dog programs. As a dog lover myself I'm thrilled to chat with Kayla today and how dogs are leaving their “paw prints” on the world. About Kayla Kayla Fratt is the founder of K9 Conservationists and Journey Dog Training. With her nonprofit K9 Conservationists, Kayla trains dogs to detect data for researchers, agencies, and NGOs. Along with the rest of the K9 Conservationists team, Kayla travels the world collecting data with her dogs and offering support to conservation detection dog programs. Her other business, Journey Dog Training, provides the financial stability and freedom to pursue the nonprofit. Journey Dog Training offers free and low-cost behavior advice to owners struggling with their pet’s behaviors. Show notes: k9conservationists.org journeydogtraining.com Patreon.com/k9-conservationists https://www.instagram.com/k9.conservationists/  https://www.facebook.com/k9conservationists  https://twitter.com/kaylafratt https://www.linkedin.com/in/kayla-fratt/  Qualio website: https://www.qualio.com/ Previous episodes: https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez
More Episodes
Listen in on our conversation with Rob Etherington, CEO of Clene Nanomedicine, a company pioneering nanotherapeutics for neurodegenerative diseases like ALS, multiple sclerosis, and Parkinson's. Rob discusses Clene's unique approach to improve mitochondrial function through a novel...
Published 04/24/24
Published 04/24/24